HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Philip F. Bongiorno Richard I. Whyte Mark B. Orringer Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bongiorno, P. F. Articles by Beer, D. G. Search for Related Content PubMed PubMed Citation Articles by Bongiorno, P. F. Articles by Beer, D. G.

J Thorac Cardiovasc Surg 1994;107:590-0595
© 1994 Mosby, Inc.

General Thoracic Surgery

Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas

Ann Arbor, Mich.

From the Section of Thoracic Surgery, University of Michigan Medical School, Ann Arbor, Mich. 48109.

Address for reprints: David G. Beer, PhD, B560 MSRBII, Box 0686, University of Michigan, Ann Arbor, MI 48109.

Abstract

The development of human adenocarcinoma of the lung involves multiple genetic changes including activation of oncogenes and loss of tumor suppressor genes. Patients whose lung tumors contain K-ras oncogene mutation, accumulation of the protein product of the tumor suppressor gene p53, or erbB-2/neu oncoprotein overexpression have been shown to have a worse prognosis. We examined these three genetic indicators in 29 lung adenocarcinomas to determine whether these markers are present in the same tumors or if they represent molecular changes that define different subsets of patients. P53 nuclear protein accumulation and erbB-2/neu protein overexpression were determined by immunohistochemical analysis of cryostat sections of tumor specimens and corresponding normal lung tissue. K-ras mutations were detected by radiolabeled oligonucleotide probes, specific for the various twelfth codon mutations, hybridized to exon 1 of K-ras, which was amplified by the polymerase chain reaction. Increased nuclear accumulation of p53 protein was found in 11 adenocarcinomas (38%). All of the p53 positive tumors were found to show high level staining and homogeneous expression of erbB-2/neu protein. K-ras mutations were detected in seven tumors (24%), all of which overexpressed erbB-2/neu. The presence of a K-ras mutation did not correlate with p53 accumulation. In total, 93% of the tumors were found to overexpress erbB-2/neu, the highest being in one tumor with erbB-2/neu gene amplification. The presence of K-ras twelfth codon mutation was associated with increased cigarette smoking. In conclusion, erbB-2/neu overexpression is a common event in lung adenocarcinomas. Furthermore, the presence of K-ras mutation and p53 protein accumulation define separate groups of patients. The mechanisms by which these genetic alterations interact or adversely affect prognosis is unknown. (J THORAC CARDIOVASC SURG 1994;107:590-5)

This article has been cited by other articles:

				C. Pellegrini, M. Falleni, A. Marchetti, B. Cassani, M. Miozzo, F. Buttitta, M. Roncalli, G. Coggi, and S. Bosari HER-2/Neu Alterations in Non-Small Cell Lung Cancer: A Comprehensive Evaluation by Real Time Reverse Transcription-PCR, Fluorescence in Situ Hybridization, and Immunohistochemistry Clin. Cancer Res., September 1, 2003; 9(10): 3645 - 3652. [Abstract] [Full Text] [PDF]

				D. G. Thomas, T. J. Giordano, D. Sanders, J. S. Biermann, and L. Baker Absence of HER2/neu Gene Expression in Osteosarcoma and Skeletal Ewing's Sarcoma Clin. Cancer Res., March 1, 2002; 8(3): 788 - 793. [Abstract] [Full Text] [PDF]

				A. Ziemba, L. C. Derosier, R. Methvin, C.-Y. Song, E. Clary, W. Kahn, D. Milesi, V. Gorn, M. Reed, and S. Ebbinghaus Repair of triplex-directed DNA alkylation by nucleotide excision repair Nucleic Acids Res., November 1, 2001; 29(21): 4257 - 4263. [Abstract] [Full Text] [PDF]

				J. Brabender, K. D. Danenberg, R. Metzger, P. M. Schneider, J. Park, D. Salonga, A. H. Holscher, and P. V. Danenberg Epidermal Growth Factor Receptor and HER2-neu mRNA Expression in Non-Small Cell Lung Cancer Is Correlated with Survival Clin. Cancer Res., July 1, 2001; 7(7): 1850 - 1855. [Abstract] [Full Text] [PDF]

				H. Allgayer, R. Babic, K. U. Gruetzner, A. Tarabichi, F. W. Schildberg, and M. M. Heiss c-erbB-2 Is of Independent Prognostic Relevance in Gastric Cancer and Is Associated With the Expression of Tumor-Associated Protease Systems J. Clin. Oncol., June 11, 2000; 18(11): 2201 - 2209. [Abstract] [Full Text] [PDF]

				S. A. Ahrendt, J. T. Chow, S. C. Yang, L. Wu, M.-J. Zhang, J. Jen, and D. Sidransky Alcohol Consumption and Cigarette Smoking Increase the Frequency of p53 Mutations in Non-Small Cell Lung Cancer Cancer Res., June 1, 2000; 60(12): 3155 - 3159. [Abstract] [Full Text]

				P. Schraml, J. Kononen, L. Bubendorf, H. Moch, H. Bissig, A. Nocito, M. J. Mihatsch, O.-P. Kallioniemi, and G. Sauter Tissue Microarrays for Gene Amplification Surveys in Many Different Tumor Types Clin. Cancer Res., August 1, 1999; 5(8): 1966 - 1975. [Abstract] [Full Text] [PDF]

				M. C. Tammemagi, J. R. McLaughlin, and S. B. Bull Meta-Analyses of p53 Tumor Suppressor Gene Alterations and Clinicopathological Features in Resected Lung Cancers Cancer Epidemiol. Biomarkers Prev., July 1, 1999; 8(7): 625 - 634. [Abstract] [Full Text]

				T. A. D'Amico, MD, M. Massey, MD, J. E. Herndon II, PhD, M.-B. Moore, and D. H. Harpole Jr A BIOLOGIC RISK MODEL FOR STAGE I LUNG CANCER: IMMUNOHISTOCHEMICAL ANALYSIS OF 408 PATIENTS WITH THE USE OF TEN MOLECULAR MARKERS J. Thorac. Cardiovasc. Surg., April 1, 1999; 117(4): 736 - 743. [Abstract] [Full Text] [PDF]

				J. A. Brennan, J. O. Boyle, W. M. Koch, S. N. Goodman, R. H. Hruban, Y. J. Eby, M. J. Couch, A. A. Forastiere, and D. Sidransky Association between Cigarette Smoking and Mutation of the p53 Gene in Squamous-Cell Carcinoma of the Head and Neck N. Engl. J. Med., March 16, 1995; 332(11): 712 - 717. [Abstract] [Full Text] [PDF]